Perceptive Advisors LLC
- SEC CIK
- 0001224962
- 最新申報
- 2026/8/14
2022 年第 2 季持倉
持倉截至 2022/6/30，2022/8/15 申報。只含多頭部位，變化是跟 2022 年第 1 季比股數。
- 持股檔數
- 109
- 較 2022 年第 1 季 −26
- 總值
- $31.8 億
- 較 2022 年第 1 季 −$16.3 億 (−33.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,867,446 | $9,522 萬 | 3.0% | −660,547−14.6% | 減碼 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 3,015,054 | $9,633 萬 | 3.0% | −877,439−22.5% | 減碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 5,321,032 | $9,924 萬 | 3.1% | +157,515+3.1% | 加碼 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 56,560,211 | $1.22 億 | 3.8% | +240,251+0.4% | 加碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 11,826,299 | $1.31 億 | 4.1% | −374,962−3.1% | 減碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 5,086,727 | $1.34 億 | 4.2% | 00.0% | 不變 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 2,866,863 | $1.92 億 | 6.0% | +486,153+20.4% | 加碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 26,895,532 | $2.89 億 | 9.1% | −660,313−2.4% | 減碼 | 歷史 |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $4.56 億 | 14.3% | – | – | – |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $742.7 萬 | – |
| FLNAFilana Therapeutics, Inc. | COM | $281.2 萬 | – |
2022 年第 1 季之後清倉（33 檔）
2022 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 1 季股數 | 2022 年第 1 季市值 | 2022 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 1,357,903 | $1.43 億 | 3.0% | 歷史 |
| Collegium Pharmaceutical, Inc19459JAA2 | NOTE 2.625% 2/1 | – | $8,947 萬 | 1.9% | – |
| NVRONevro Corp | COM | 477,037 | $3,450 萬 | 0.7% | 歷史 |
| PENPenumbra Inc | COM | 143,591 | $3,190 萬 | 0.7% | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 501,509 | $2,314 萬 | 0.5% | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 616,141 | $2,239 萬 | 0.5% | 歷史 |
| AXNXAxonics, Inc. | COM | 341,211 | $2,136 萬 | 0.4% | 歷史 |
| LUNGPulmonx Corp | COM | 537,779 | $1,334 萬 | 0.3% | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 405,000 | $1,278 萬 | 0.3% | 歷史 |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $1,104 萬 | 0.2% | – |
| HLTHCue Health Inc. | COM | 1,580,607 | $1,020 萬 | 0.2% | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 1,000,000 | $987.0 萬 | 0.2% | – |
| Summit Healthcre Acquistn CoG8566R128 | UNIT 06/03/2026 | 1,000,000 | $977.7 萬 | 0.2% | – |
| RACBResearch Alliance Corp. II | COM CL A | 1,000,000 | $976.0 萬 | 0.2% | 歷史 |
| EVHEvolent Health, Inc. | CL A | 250,000 | $807.5 萬 | 0.2% | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 284,853 | $689.9 萬 | 0.1% | 歷史 |
| ACCDAccolade, Inc. | COM | 330,682 | $580.7 萬 | 0.1% | 歷史 |
| MRUSMerus N.V. | COM | 209,046 | $552.7 萬 | 0.1% | 歷史 |
| DALSDA32 Life Science Tech Acquisition Corp. | CLASS A COM | 500,000 | $485.8 萬 | 0.1% | 歷史 |
| SGHTSight Sciences, Inc. | COM | 390,000 | $450.8 萬 | 0.1% | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 450,000 | $446.0 萬 | 0.1% | 歷史 |
| NVTAInvitae Corp | COM | 554,585 | $442.0 萬 | 0.1% | 歷史 |
| IMRXImmuneering Corp | CLASS A COM | 681,051 | $440.6 萬 | 0.1% | 歷史 |
| NARIInari Medical, Inc. | Stock | 30,000 | $271.9 萬 | 0.1% | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 65,144 | $238.2 萬 | <0.1% | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 325,854 | $166.2 萬 | <0.1% | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 44,475 | $145.7 萬 | <0.1% | 歷史 |
| ONCROncorus, Inc. | COM | 752,241 | $133.9 萬 | <0.1% | 歷史 |
| RPIDRapid Micro Biosystems, Inc. | CLASS A COM | 190,745 | $129.5 萬 | <0.1% | 歷史 |
| Rockley Photonics Holdings LG7614L117 | *W EXP 08/11/202 | 500,000 | $42.5 萬 | <0.1% | – |
| Butterfly Network, Inc.124155110 | *W EXP 05/27/202 | 233,333 | $23.8 萬 | <0.1% | – |
| SLGCWSomaLogic, Inc. | *W EXP 03/01/202 | 110,000 | $23.5 萬 | <0.1% | 歷史 |
| UTRSMinerva Surgical Inc | COM | 50,268 | $22.6 萬 | <0.1% | 歷史 |